Improvement in QoL With Controlled
Ileal-Release Budesonide in Active CD
*p<0.005
†p<0.01 compared with placebo
80
130
-20
180
30
Placebo
Budesonide3 mg
Budesonide 9 mg
Budesonide15 mg
Treatment Group
*
*
†
Baseline
2 weeks
8 weeks
Text Box: Mean IBDQ Score
Mean IBDQ Score
†
B
E
T
T
E
R
Irvine EJ et al. Inflamm Bowel Dis. 2000;6:181.